IndraLab

Statements

Amodiaquine inhibits glycoprotein-dependent entry EBOV. 1 / 1

| 1

➶

eidos

"Amodiaquine and its derivatives inhibit glycoprotein-dependent entry of EBOV ."

30395872

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Amodiaquine inhibits glycoprotein-dependent entry EBOV. 1 / 1

INDRA sources:

Databases

Reading